Board of Advisors
Dr. Bruce L. Miller
Advisor
Dr. Miller holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at the University of California, San Francisco (UCSF), where he also directs the Memory and Aging Center (MAC), an NIH-sponsored Alzheimer’s Disease Research Center. A behavioral neurologist, Dr. Miller helped found the Global Brain Health Institute (GBHI) and the Atlantic Fellows for Equity in Brain Health program. GBHI works to reduce the scale and impact of dementia around the world by training and supporting the next generation of leaders to translate research evidence into expanding preventions and interventions.
Dr. Miller has received numerous awards, including the Potamkin Award from the American Academy of Neurology, the Raymond Adams Award
from the American Neurological Association, and the Gene D. Cohen Research Award in Creativity and Aging from the National Center for Creative Aging. He has authored The Human Frontal Lobes, The Behavioral Neurology of Neurology, Frontotemporal Dementia, Finding the Right Words and over 1,000 other publications regarding dementia. His work has been featured in Fortune magazine, the New York Times, 60 Minutes and PBS NewsHour, among others.
Eliezer Masliah, M.D.
Federal Liason
Dr. Masliah is the Director of the Division of Neuroscience at the National Institute on Aging (NIA). He received his M.D. from the National Autonomous University of Mexico and completed postgraduate training in pathology at the National Institutes of Health in Mexico City, and in neuropathology and neurodegenerative disorders at the University of California, San Diego (UCSD). Before joining NIA, he held joint faculty appointments at the Departments of Neurosciences and Pathology and as Director of the Autopsy Service at UCSD Medical Center. Dr. Masliah provides leadership on NIH-sponsored programs dedicated to better understanding brain aging and Alzheimer’s disease. The division plays a key role in developing the implementation of milestones for the National Plan to Address Alzheimer’s Disease, which calls for the identification
of effective ways to treat or prevent Alzheimer’s disease and related dementias by 2025. A prolific author, Dr. Masliah has published approximately 800 original research articles, 70 book chapters and holds dozens of patents. Dr. Masliah provides leadership on NIH-sponsored programs dedicated to better understanding brain aging and Alzheimer’s disease. The division plays a key role in developing the implementation of milestones for the National Plan to Address Alzheimer’s Disease, which calls for the identification of effective ways to treat or prevent Alzheimer’s disease and related dementias by 2025. A prolific author, Dr. Masliah has published approximately 800 original research articles, 70 book chapters and holds dozens of patents.
Patrick Brannelly, MSc, MBA
Advisor
Patrick Brannelly is the founding CEO of the 10,000 Brains Project, a philanthropic fund that supports the application of AI for solving Alzheimer’s disease and related neurodegenerative disorders. Pat has more than 20 years of experience building groundbreaking neuroscience initiatives. Most recently, he was a Director of Health & Life Sciences at Gates Ventures, where his work focused on building partnerships for the non-profit Alzheimer’s Disease Data Initiative (ADDI). Prior to this, he was the Managing Director of the Rainwater Foundation’s Tau Consortium, which seeks to accelerate the development of new treatments for Alzheimer’s disease and frontotemporal dementia. Pat holds a BA in Psychology from Harvard College, an MBA with Distinction from Harvard Business School, and an MSc in Applied Neuroscience with Distinction from King’s College London.